Neomorph is a biotech company targeting protein degradation to eliminate disease-linked and previously labeled 'undruggable' proteins. The team's expertise in protein degradation and molecular glues allows them to develop heterobifunctional molecules that can degrade proteins using a molecular glue mechanism. Neomorph is collaborating with the Center for Protein Degradation at the Dana Farber Cancer Institute, as well as Novo Nordisk to discover and develop drugs for cardiometabolic and rare diseases. They were founded in 2020 with headquarters located in San Diego, CA.

Neomorph

Associate Scientist

Principal Software Engineer

Intern - Computational Chemistry

Associate Director of Chemistry

 Sticky, sticky, sticky: Neomorph tacks on another Big Pharma glue degrader deal with $1.6B AbbVie pact 

Highlighting Fan Zheng for their remarkable achievements and hard work. 

Thank you for your commitment.

Alien: Covenant Concept Art Reveals Early Neomorph Design - Screen Rant

We're #hiring a new Sr Scientist, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

Alien: Covenant Photos Reveal Baby Neomorph, Ancient Temple & More - MovieWeb

What is 'The Offspring' creature in the 'Alien: Romulus' finale? - Space

We're #hiring a new Senior Scientist, Computational Chemistry in San Diego, California. Apply today or share this post with your network.

 Appointments and advancements for Jan. 15, 2025 

Last week, a few of our incredible female scientists participated in Women Who Inspire 2025, an event that celebrates the achievements, leadership, and impact of women in STEM. It was an inspiring day of connection, empowerment, and thought-provoking discussions.
 
At Neomorph, we’re proud to support and uplift the voices of women driving scientific breakthroughs. Thank you to Biocom California for hosting such an empowering event!

#WomenWhoInspire2025 #WomenInSTEM #LifeSciences #NeomorphInc #Biotech #Leadership #Biocom

Molecular Glue Degraders Get Stickier With AbbVie/Neomorph Deal - insights.citeline.com

We're #hiring a new Senior / Executive Director, CMC in San Diego Metropolitan Area. Apply today or share this post with your network.

 Neomorph Inks $1.46B Deal with Novo Nordisk 


                    Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
                

Morphological evolution of the neomorph in Choristodera. Red branches... - ResearchGate

Carlos Huante Shares Neomorph Concept Art & Storyboards - Alien vs. Predator Galaxy

Novo Nordisk signs $1.46bn deal to develop molecular glue therapies - Pharmaceutical Technology

Novo Nordisk joins protein degradation race in $1.4B+ deal with Neomorph - FirstWord Pharma

New ‘Alien: Covenant’ Photos Reveal the Neomorph in All Its Gruesome Glory - ScreenCrush

How Does Alien: Romulus Connect To Prometheus? - TheGamer

 Neomorph, Inc. Announces Appointment of Chief Financial Officer 

 Neomorph Pulls $109 Million 

Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact - MM+M Online

Check out the Terrifying new Neomorph in Ridley Scott’s Alien: Covenant - Motion Picture Association

Novo Nordisk joins molecular glue club with Neomorph deal - pharmaphorum

 Neomorph Lands $1.45B Biogen Pact 

 Neomorph’s $1.6 Billion Collaboration with AbbVie 

 AbbVie partners with Neomorph in latest molecular glue deal 

‘Alien: Covenant’: How the VFX Team Engineered Those Terrifying Xenomorph and Neomorph Creatures - IndieWire

We're #hiring a new Executive / Senior Executive Administrative Assistant in San Diego Metropolitan Area. Apply today or share this post with your network.

We're #hiring a new Assoc. Scientist, Analytical Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

NECA Alien Covenant Creatures - AvP Galaxy

 Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform 

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - Biogen | Investor Relations

 AbbVie and Neomorph seal glue degrader deal 

AVERON notebook to discover actionable cancer vulnerabilities enabled by neomorph protein-protein interactions - ScienceDirect.com

 Novo Nordisk sticks down $1.46B in biobucks for molecular glues 

 Novo Nordisk signs $1.46bn deal to develop molecular glue therapies 

Neomorph, Inc. Announces Appointment of Chief Financial Officer - Business Wire

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders - Inside Precision Medicine

 Novo Nordisk moves into glue degrader sector with Neomorph deal 

 Neomorph, Abbvie to develop molecular glue degraders in $1.64B deal 

Fox Continues To Explore VR’s Selling Power With “Alien: Covenant In Utero” - Fast Company

AbbVie, Neomorph partner on protein degrader drugs - Investing.com

My Life as a Teenaged Neomorph: Experiencing ‘Alien Covenant: In Utero’ - The Knoxville Mercury

 Already struggling booze biz dealt a new challenge: Crain's Daily Gist podcast 

Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal - geneonline.com

Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B - Fierce Biotech

Biogen and Neomorph enter molecular glue degrader deal - Yahoo Finance

Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform - BioSpace

Neomorph Vs. Xenomorph Fight Almost Happened in Alien: Covenant - MovieWeb

Up to $1.45 billion on the line in Biogen and Neomorph deal - The Pharma Letter

We're #hiring a new Scientist II, Biomolecular Simulations - Comp Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

Click here


              Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
            

We're #hiring a new Director, DMPK in San Diego, California. Apply today or share this post with your network.

Biogen signs molecular glue deal, raises yearly projections - Endpoints News

AbbVie and Neomorph to develop glue degraders - Pharmaceutical Technology

Biogen, Neomorph to collaborate on clinical candidates for Alzheimer's (NASDAQ:BIIB) - Seeking Alpha

 AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B 

 Biogen, Neomorph announces multi-target research collaboration 

Ridley Scott: Inspiration for Alien: Covenant's Neomorph - IGN

Alien: Covenant - Get a Closer Look at the Neomorph - IGN Nordic

Alien: Covenant Images Feature Neomorphs & Prometheus Connection - Screen Rant

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - StockTitan

AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology - PR Newswire

Highlighting our Neomorph Operations team as they lead our lab's charge into the future!

AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B - BioSpace

Neomorph Lands $1.45B Biogen Pact - San Diego Business Journal

Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors - PR Newswire

Biogen forges $1.4B+ deal with Neomorph around molecular glue degraders - FirstWord Pharma

 AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology 

Sticky, sticky, sticky: Neomorph tacks on another Big Pharma glue degrader deal with $1.6B AbbVie pact - Fierce Biotech

 Substituted 2-(2,6-dioxopiperidin-3-yl)-5-(1-piperidin-4-yl)isoindoline-1,3- … 

Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs - Business Wire

Life-Sized ALIEN: COVENANT Neomorph Head Statue Is Mortifying - Nerdist

Celebrating Hidetomo I. for his dedication, passion, and outstanding contributions to our team!

Biogen, Neomorph partner to advance molecular glue degraders for neurologic conditions - Healio

We're #hiring a new Corporate Controller in San Diego Metropolitan Area. Apply today or share this post with your network.

'Alien: Covenant In Utero' Lets You Experience a Neomorph Birth in VR - Space.com

UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G, Weng S, Matyskiela M, Zheng X, Fang W, Wood S, Surka C, Mizukoshi R, Lu CC, Mendy D, Jang IS, Wang K, Marella M, Couto S, Cathers B, Carmichael J, Chamberlain P, Rolfe M. Elife. 2018 Sep 20;7:e40958. doi: 10.7554/eLife.40958. PMID: 30234487; PMCID: PMC6185104.
                    

AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn - PMLiVE

Neomorph, Inc.

Neomorph Inks $1.46B Deal with Novo Nordisk - San Diego Business Journal

Alien: 5 Reasons Why Neomorphs Are Deadlier Than Xenomorphs (& 5 Why They're Not) - Screen Rant

 Novo Nordisk joins molecular glue club with Neomorph deal 

‘Alien: Covenant’ VFX Team Hatches New Neomorph, Xenomorphs - Hollywood Reporter

Neomorph - Alien Guide - IGN

Neomorph - Alien vs. Predator Galaxy

Alien: Covenant's Neomorph Gets a Funko Vinyl Figure - Screen Rant

Protocol to discover actionable cancer vulnerabilities enabled by neomorph protein-protein interactions with the AVERON Notebook - ScienceDirect.com

There Was Going to Be a Xenomorph vs Neomorph Fight in ‘Alien: Covenant’ - Bloody Disgusting

We're #hiring a new Scientist II, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

Click here for Webcast

Novo Nordisk and Neomorph enter molecular glue degrader partnership worth over $1.4bn - PMLiVE

Neomorph Appoints Philip Chamberlain As CEO - citybiz


                    Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks – Targeted Protein Degradation Day
                

https://neomorph.com/index.html#news

 Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer 


                    Philip Chamberlain Named as Chief Executive Officer of Neomorph
                

Neomorph

About: